Novo Nordisk invests more than 2.1 billion euros to expand the existing production site in Chartres, France.
Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 2023 to expand the existing production site in Chartres, France, for the current and future product portfolio within serious chronic diseases. The investment…